Synedgen begins SynePure plus Catasyn trial to treat partial thickness burns
Both SynePure and Catasyn are wound care medical devices that have secured 510(k) clearance from the FDA
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Both SynePure and Catasyn are wound care medical devices that have secured 510(k) clearance from the FDA
The next-generation remedē EL-X system is designed to simplify the implant procedure and provide improved device longevity for…
PCCR is engaged in designing, validation, moulding and assembly of plastic components and sub-assemblies for medical device products
The new imaging software combines OCT with AI to deliver a comprehensive view of coronary blood flow and…
Paramit has developed and produced various FDA-accepted and CLIA-waived medical devices
CryoLife aims to use proceeds from the deal for general corporate purposes, contingent consideration obligations, and potential debt…
OncoMate MSI is used to determine microsatellite instability status in colorectal cancer tumours
The company will use the proceeds for the commercialisation of eXciteOSA in its core target markets
DYSIS View will allow healthcare professionals to identify cervical lesions more clearly
Veritas Vision System will help address three critical areas such as patient safety, surgeon efficiency and comfort